Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 51 citing Katlama: Efficacy and tolerability of stavudine plus lamivudine in treatment-naive and treatment-.... (0.10 sec) 

Differential removal of thymidine nucleotide analogues from blocked DNA chains by human …

- nih.gov
PR Meyer, SE Matsuura, RF Schinazi, AG So, … - Antimicrobial agents and chemotherapy, 2000 - Am Soc Microbiol
Removal of 2',3'-didehydro-3'-deoxythymidine-5'-monophosphate (d4TMP) from a
blocked DNA chain can occur through transfer of the chain-terminating residue to
a nucleotide acceptor by human immunodeficiency virus type 1 (HIV-1) ...
Cited by 92 - Related articles - BL Direct - All 5 versions

A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir …


JJ Eron Jr, RL Murphy, D Peterson, J Pottage … - Aids, 2000 - journals.lww.com
From the University of North Carolina School of Medicine, Chapel Hill, NC, a
Northwestern University Medical School, Chicago IL, b University of Texas
Southwestern Medical Center, Dallas TX, c Rush Medical College, Chicago IL, ...
Cited by 89 - Related articles - BL Direct - All 3 versions

A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination …


KE Squires, R Gulick, P Tebas, J Santana, V … - Aids, 2000 - journals.lww.com
From the University of Alabama at Birmingham, Birmingham, Alabama, a Weill
Medical College of Cornell University and New York University, New York, New
York, b Washington University School of Medicine, St. Louis, Missouri, c ...
Cited by 88 - Related articles - BL Direct - All 3 versions

Zidovudine triphosphate and lamivudine triphosphate concentration-response relationships …


CV Fletcher, SP Kawle, TN Kakuda, PL … - Aids, 2000 - journals.lww.com
Skip Navigation Links Home > September 29, 2000 - Volume 14 - Issue 14 >
Zidovudine triphosphate and lamivudine triphosphate concentr... ... Fletcher,
Courtney V.; Kawle, Sagar P.; Kakuda, Thomas N.; Anderson, Peter L.; ...
Cited by 84 - Related articles - BL Direct - All 3 versions

Human immunodeficiency virus and host cell lipids. Interesting pathways in research for a …


J Raulin - Progress in Lipid Research, 2002 - Elsevier
It has been reported in the literature that biological membranes arising from
HIV-induced cell fusion, as well as syncytium formation between infected and
non-infected cells and those involved in transduction, viral DNA nuclear ...
Cited by 53 - Related articles - BL Direct - All 6 versions

Probing the Molecular Mechanisms of AZT Drug Resistance Mediated by HIV-1 Reverse …

- tulane.edu [PDF] 
AS Ray, E Murakami, A Basavapathruni, JA … - Biochemistry, 2003 - pubs.acs.org
Work supported by NIH Grants GM49551 (KSA), R37AI-41980 (RFS), AI 25899 (CKC),
and RO1AI-32351 (RFS and CKC), the Department of Veteran Affairs (RFS), NRSA 5
T32 GM07223 from the National Institute of General Medical Sciences (ASR), ...
Cited by 52 - Related articles - BL Direct - All 6 versions

The emergence of different resistance mechanisms toward nucleoside inhibitors is explained …


C Isel, C Ehresmann, P Walter, B Ehresmann, … - Journal of Biological Chemistry, 2001 - ASBMB
Nucleoside reverse transcriptase inhibitors (NRTIs) represent one of the main
drug families used against AIDS. Once incorporated in DNA, they act as chain
terminators, due to the lack of a 3′-hydroxyl group. As for the other ...
Cited by 48 - Related articles - BL Direct - All 4 versions

Impact of stavudine phenotype and thymidine analogues mutations on viral response to …


V Calvez, D Costagliola, D Descamps, A Yvon, … - Antiviral therapy, 2002 - ncbi.nlm.nih.gov
OBJECTIVE: Stavudine-based antiretroviral combinations are less effective in
zidovudine-experienced patients than in naive subjects and recently, mutations
have been described to be associated to the use of both stavudine and ...
Cited by 48 - Related articles - BL Direct - All 4 versions

Consensus statement: anemia in HIV infection—current trends, treatment options, and …


P Volberding - Clinical therapeutics, 2000 - Elsevier
Despite important advances in antiretroviral therapy, anemia remains a problem
in many HIV-infected patients. Although the incidence of anemia in these
patients has decreased, its prevalence appears to have stabilized or ...
Cited by 48 - Related articles - BL Direct - All 5 versions

Highly active antiretroviral therapy (HAART) for the treatment of infection with human …


RW Shafer, DA Vuitton - Biomedicine & Pharmacotherapy, 1999 - Elsevier
Highly active antiretroviral therapy (HAART) refers to a broad category of
treatment regimens usually comprised of three or more antiretroviral drugs that,
in previously untreated HIV-1-infected patients, are expected to reduce ...
Cited by 47 - Related articles - All 4 versions


Result Page: 

1

2

3

4

5

6

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google